Glenmede Quant International Equity GTCIX

Medalist Rating as of | See Glenmede Investment Hub
  • NAV / 1-Day Return 17.85  /  +0.51 %
  • Total Assets 28.1 Mil
  • Adj. Expense Ratio
    1.000%
  • Expense Ratio 1.000%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 2.97%
  • Turnover 84%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:16 PM GMT+0

Morningstar’s Analysis GTCIX

Will GTCIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Glenmede Quant International Equity's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GTCIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Volvo AB Class B

2.30 588,291
Industrials

Cochlear Ltd

2.08 531,785
Healthcare

Honda Motor Co Ltd

2.03 519,560
Consumer Cyclical

Manulife Financial Corp

1.94 497,965
Financial Services

Novo Nordisk A/S Class B

1.92 490,966
Healthcare

Japan Tobacco Inc

1.86 475,634
Consumer Defensive

BAE Systems PLC

1.82 467,211
Industrials

GSK PLC

1.80 459,830
Healthcare

Henkel AG & Co KGaA Participating Preferred

1.77 454,535
Consumer Defensive

Novartis AG Registered Shares

1.76 449,568
Healthcare

Sponsor Center